Sign in

CIK 0001557376

  • Non-accelerated filer
  • Smaller reporting company

Zeo ScientifiX, Inc.

Sign in to watch
Ticker
ZEOX
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
NV
Entity type
Operating
EIN
474180540
Phone
+1 888-963-7881
Business address
3321 COLLEGE AVENUE, SUITE 246, DAVIE, FL, 33314
Former names
Organicell Regenerative Medicine, Inc., Biotech Products Services & Research, Inc., BESPOKE TRICYCLES INC
  1. 4 Grant or award Chief Science Officer acquired 15,000,000 shares (grant or award)
  2. 4 Open-market buy Director bought 422,514 shares at $0.10 ($42,251)
  3. 4 Grant or award Chief Financial Officer acquired 15,000,000 shares (grant or award)
  4. 4/A Grant or award Chief Financial Officer acquired 5,000,000 shares (grant or award)
  5. 4 Grant or award CEO and President acquired 15,000,000 shares (grant or award)
  6. 4 Grant or award Chief Science Officer acquired 28,000,000 shares (grant or award)
  7. 4 Grant or award Former Director acquired 736,808 shares (grant or award)
  8. 4 Grant or award Chief Medical Officer acquired 28,000,000 shares (grant or award)
  9. 4 Grant or award Chief Financial Officer acquired 23,500,000 shares (grant or award)
  10. 4 Grant or award CEO and President acquired 28,000,000 shares (grant or award)
  11. 4 Open-market buy Director bought 12,016,666 shares at an average $0.02 ($252,000)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Grant or award Chief Medical Officer acquired 5,000,000 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 5 Insider Annual Insider Trading Report
  16. 5 Insider Annual Insider Trading Report
  17. 4 Grant or award Chief Financial Officer acquired 5,675,439 shares (grant or award)
  18. 4 Grant or award Chief Science Officer acquired 2,092,105 shares (grant or award)
  19. 4 Grant or award President acquired 2,092,105 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 9 of 10 · 197 filings